Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 9
Maximum Age: 64
Healthy Volunteers: t
View:
• Age 9 through 64 years
• Diagnosed with COVID-19 at least 2 months prior enrollment
• Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
• Patients without COVID-19 diagnosis for controls
Locations
United States
California
Stanford University
RECRUITING
Palo Alto
Contact Information
Primary
SNP Center Inquiry
snpcenterallergy_inquiry@stanford.edu
(650) 521-7237
Time Frame
Start Date: 2020-10-29
Estimated Completion Date: 2026-04
Participants
Target number of participants: 230
Treatments
COVID-19 participants
Control participants
Authors
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Leads: Stanford University